ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "osteoporosis"

  • Abstract Number: 1329 • ACR Convergence 2022

    Prevalence of Bone Fragility on DXA and CT in Patients with Obesity

    Marion Halin1, Edem Allado1, Didier Quilliot1, Eliane Albuisson1, Isabelle Chary-Valckenaere1, Damien Loeuille1, Laurent Brunaud1 and Marine FAUNY2, 1Nancy University Hospital, Vandoeuvre, France, 2Nancy University Hospital, Toul, France

    Background/Purpose: Primary objective was to evaluate bone fragility prevalence on dual X-ray absorptiometry (DXA) and on computed tomography (CT), in patients with severe obesity. Secondary…
  • Abstract Number: 0502 • ACR Convergence 2022

    The Effect of Osteoporosis on Developing Vertebral Compression Fracture After Single-level Posterior Lumbar Fusion Surgery: A Large Healthcare Claims Database Study

    Vartika Kesarwani1, Sean Esmende2, Regina Kostyun2, Matthew Solomito2, Heeren Makanji2, John Magaldi2 and Mandeep Kumar2, 1University of Connecticut, Farmington, CT, 2Bone and Joint Institute, Hartford Hospital, Hartford, CT

    Background/Purpose: Vertebral compression fracture (VCF) is a significant osteoporosis-related complication (ORC) associated with instrumented spinal fusion. Various studies have assessed the development of VCF in…
  • Abstract Number: 1310 • ACR Convergence 2022

    Is the Trabecular Bone Score (TBS) a Useful Tool in Patients with Diffuse Idiopathic Skeletal Hyperostosis (DISH)?

    Bjoern Buehring1, David Kiefer2, Celina Mueller2, Roshnak Parvaee2, Marianti Ifanti2, Ioana Andreica3, Timm Westhoff4, Rainer Wirth4, Xenofon Baraliakos5, Nina Babel4 and Juergen Braun2, 1Bergisches Rheuma-Zentrum, Wuppertal, Germany, 2Rheumazentrum Ruhrgebiet, Herne, Germany, 3Rheumazentrum Ruhrgebiet, Ruhr-Universität-Bochum, Herne, Germany, 4Marienhospital Herne, Ruhr-University Bochum, Herne, Germany, 5Rheumazentrum Ruhrgebiet Herne, Herne, Germany

    Background/Purpose: Patients with rheumatic and musculoskeletal diseases (RMD) have an increased fracture risk (FxR). Diffuse idiopathic skeletal hyperostosis (DISH) is a non-inflammatory disease characterized by…
  • Abstract Number: 1331 • ACR Convergence 2022

    Risk Factors for Osteoporotic Fracture in Women with Established Long-Term Rheumatoid Arthritis

    Felipe Freire da Silva1, Gisela Machado2, ana Medeiros3, Karina Bonfiglioli4, Andrea Shimabuco2, Liliam Takayama5, Rosa Pereira6 and Diogo Domiciano7, 1FMUSP, Salvador, Brazil, 2FMUSP, São Paulo, Brazil, 3Faculdade de Medicina da Universidade de São Paulo, São Jose Dos Campos, Brazil, 4Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, 5University of São Paulo, São Paulo, Brazil, 6Bone Metabolism Laboratory, Rheumatology Division, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, 7Hospital das Clinicas, Rheumatology Division, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil

    Background/Purpose: Low bone mineral density (BMD) is a predictor of osteoporotic fracture. However, individuals with Rheumatoid Arthritis (RA) who sustain "osteoporosis-related" fractures frequently have normal…
  • Abstract Number: 0574 • ACR Convergence 2022

    Osteoporosis in Elderly Men; An Underestimated and Underdiagnosed Morbid Entity

    Arash Mollaeian1 and Stanley Ballou2, 1Metro Health Medical Center/Case Western Reserve University, Rocky River, OH, 2Case Western Reserve University - Metro Health, Cleveland, OH

    Background/Purpose: 20-25% of osteoporosis-related fractures occur in men and the mortality of osteoporotic fractures is higher in men [1]. Nevertheless, no uniform consensus exists for…
  • Abstract Number: 1312 • ACR Convergence 2022

    Cost-Effectiveness of Sequential Treatment with Abaloparatide Followed by Alendronate in US Men at High Risk of Fracture

    Mickael Hiligsmann1, Stuart Silverman2, Andrea J Singer3, Leny Pearman4, jake Mathew4, Yamei Wang4, John Caminis4 and Jean-Yves Reginster5, 1Maastricht University, Maastricht, Netherlands, 2Cedar-Sinai Medical Center and UCLA School of Medicine, Los Angeles, CA, 3MedStar Georgetown University Hospital, Washington, DC, 4Radius Health, Inc., Waltham, MA, 5University of Liège, Liège, Belgium

    Background/Purpose: Previous cost-effectiveness analyses in postmenopausal women (PmW) with osteoporosis (OP) demonstrated that sequential treatment with abaloparatide (ABL) followed by alendronate (ALN) resulted in lower…
  • Abstract Number: 1338 • ACR Convergence 2022

    Patients’ Perspectives and Experiences of Medication Use in Osteoporosis – a Qualitative Systematic Review and Thematic Synthesis

    Sagarika Dey1, Gloria Spratt2, Muguet Koobasi3, Carol Vleeskens4, Carlos El-Haddad5 and Ayano Kelly6, 1School of Clinical Medicine, South Western Sydney Campus, University of New South Wales, Parramatta, New South Wales, Australia, 2Physiotherapy Department and Rheumatology Department, Liverpool Hospital; Zone34 Sports Physiotherapy, Liverpool, Australia, 3Knowledge Centre for Health Ghent, Ghent University, Ghent, Belgium, 4Sydney Partnership for Health Medical Research and Enterprise Consumer Community Council, Liverpool, Australia, 5Rheumatology Department, Liverpool Hospital, Liverpool, Australia, 6South Western Sydney Campus, UNSW Medicine & Health, Braddon, Australia

    Background/Purpose: Suboptimal adherence to anti-osteoporotic medications presents a growing social and economic concern. Yet, it is unclear what patients' perspectives and experiences are regarding medication…
  • Abstract Number: 0575 • ACR Convergence 2022

    Myocardial Infarction and Stroke Risks Among Patients Who Initiated Treatment with Denosumab or Zoledronic Acid for Osteoporosis

    Leslie Spangler1, Carrie Nielson1, M Alan Brookhart2, Rohini K Hernandez1, Robert Kees Stad3 and Jay Lin1, 1Amgen, Inc., Thousand Oaks, CA, 2NoviSci, Inc., Durham, NC, 3Amgen Inc., Zug, Switzerland

    Background/Purpose: There has been inconsistent evidence published regarding the cardio- and cerebrovascular benefits and risks of anti-osteoporosis medications. EU regulators requested Amgen to evaluate the…
  • Abstract Number: 1313 • ACR Convergence 2022

    The Role of Tryptophan and Its Metabolites in Risk for Incident Hip Fractures and Frailty: The Cardiovascular Health Study

    Laura Carbone1, Petra Bůžková2, John Robbins3, Howard Fink4, Joshua Barzilay5, Rachel Elam1 and Carlos Isales1, 1Augusta University, Augusta, GA, 2University of Washington, Seattle, WA, 3UC Davis, Davis, CA, 4University of Minnesota, Minneapolis, MN, 5Kaiser Permanente, Atlanta, GA

    Background/Purpose: Essential amino acids including tryptophan (trp) are building blocks for protein, and adequate protein intake is important for skeletal homeostasis. In experimental studies, trp…
  • Abstract Number: 1477 • ACR Convergence 2022

    Prevalence and Risk Factors of Fragility Fractures in Systemic Lupus Erythematosus: A Longitudinal Study over 12 Years

    Chi Chiu Mok1, Kar Li Chan2, Ling Yin Ho3 and Chi Hung To4, 1Tuen Mun Hospital, Hong Kong, China, 2Tuen Mun Hospital, Tsing Yi, Hong Kong, China, 3Tuen Mun Hospital, Hong Kong SAR, China, 4Hospital Authority, Hong Kong, Hong Kong

    Background/Purpose: To study the prevalence and risk factors of fragility fractures in a longitudinal cohort of patients with SLE.Methods: All patients who fulfilled ≥4 1997…
  • Abstract Number: 0576 • ACR Convergence 2022

    Comparative Effectiveness of Osteoporosis (OP) Therapies Among a Population of Postmenopausal (PM) Women in the United States (U.S.)

    Min Kim1, Leah J McGrath2, David Pritchard2, Peter Samai2, Jay Lin1, Robert Kees Stad3, Leslie Spangler1, Michele McDermott1, Brian D Bradbury4 and M Alan Brookhart2, 1Amgen, Inc., Thousand Oaks, CA, 2NoviSci, Inc., Durham, NC, 3Amgen Inc., Zug, Switzerland, 4Amgen Inc., 1 Amgen Center Drive

    Background/Purpose: Although clinical trials evaluating the efficacy of osteoporosis (OP) therapies have shown that denosumab (Dmab) significantly increases bone mineral density at pivotal sites compared…
  • Abstract Number: 1314 • ACR Convergence 2022

    Response Rates for Lumbar Spine, Total Hip, and Femoral Neck Bone Mineral Density with Abaloparatide in Men: Results from the ATOM Study

    Ruban Dhaliwal1, David Kendler2, Kenneth Saag3, Steven Ing4, Andrea Singer5, Robert Adler6, Leny Pearman7, Yamei Wang7 and Bruce Mitlak8, 1SUNY Upstate Medical University, Syracuse, NY, 2University of British Columbia, Vancouver, BC, Canada, 3University of Alabama at Birmingham, Birmingham, AL, 4Ohio State University Wexner Medical Center, Colombus, OH, 5MedStar Georgetown University Hospital, Washington, DC, 6Hunter Holmes McGuire Veterans Affairs Medical Center-Richmond, Richmond, VA, 7Radius Health, Inc., Waltham, MA, 8Radius Health, Inc, Boston, MA

    Background/Purpose: In the Abaloparatide for the Treatment of Men with Osteoporosis (ATOM) study, 12 months of abaloparatide therapy resulted in rapid and significant improvements in…
  • Abstract Number: 1826 • ACR Convergence 2022

    Association of High Uric Acid Levels with Low Bone Mineral Density in Pre- but Not Post-menopausal Women with Rheumatoid Arthritis

    Sandra Hermann1, Andriko Palmowski1, Bukrhard Muche2, Kay-Geert Hermann3, Edgar Wiebe1 and Frank Buttgereit4, 1Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany, 2Charité University Hospital, CCM, Berlin, Germany, 3Charité - Universitätsmedizin Berlin, Berlin, Germany, 4Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin / DRFZ Berlin, Berlin, Germany

    Background/Purpose: Uric acid is controversially discussed regarding its effect on bone health. Higher uric acid levels have been associated with higher T-scores and fewer bone…
  • Abstract Number: 1135 • ACR Convergence 2021

    Osteoporosis Assessment and Outcomes in Candidates for Liver Transplantation in a Tertiary Center

    Cristina Rodríguez-Alvear1, MARIANO ANDRES1, Maria-Luisa Peral-Garrido2, Irene Calabuig3, Ernesto Tovar-Sugrañes1, Mari-Carmen López-González1, Pilar Bernabeu1, Agustín Martínez-Sanchis1, Ximo Esteve1, Paloma Vela1, Cayetano Miralles1 and Maria Vega Jovani Casano4, 1Hospital General Universitario de Alicante-ISABIAL, Alicante, Spain, 2Hospital General Universitario de Alicante-ISABIAL, Novelda, Spain, 3Hospital General Universitario de Alicante, Alicante, Spain, 4National Health system, Alicante, Spain

    Background/Purpose: A rapid loss of bone mass and an increase in fractures have been described in the first six months after liver transplantation. This phenomenon…
  • Abstract Number: 1137 • ACR Convergence 2021

    REMS Technology for the Assessment of Bone Health in a Male Population

    Delia Ciardo1, Paola Pisani1, Fiorella Anna Lombardi1, Marco Di Paola1, Roberto Franchini1, Maurizio Muratore2, Francesco Conversano1 and Sergio Casciaro1, 1National Research Council, Institute of Clinical Physiology, Lecce, Italy, Lecce, Italy, 2Vito Fazzi Hospital, ASL-LE, O.U. of Rheumatology, Lecce, Italy, Lecce, Italy

    Background/Purpose: This study aimed to evaluate the diagnostic accuracy of the ultrasound-based densitometric technology called Radiofrequency Echographic Multi Spectrometry (REMS) in the diagnosis of osteoporosis…
  • « Previous Page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 20
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology